Showing results (141-150 of 668) with videos related to
Sort By:
Pageof 67
Neuropharmacology|July 1, 1995
Dopamine-induced reduction in the density of guanine nucleotide-sensitive D1 receptors in human postmortem brain in the absence of apparent D1: D2 interactionsP G McCauley, K M O'Boyle, J L WaddingtonLife Sciences|June 13, 1983
Irreversible interaction of beta-haloalkylamine derivatives with dopamine D1 and D2 receptorsA J Cross, J L Waddington, S T RossSchizophrenia Research|July 6, 2001
Is reduced dermatoglyphic a-b ridge count a reliable marker of developmental impairment in schizophrenia?P Fearon, A Lane, M Airie, et al.BMC Urology|May 24, 2023
Seminal papers in urology: anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinenceNathan Shugg, Michael E O'CallaghanThe British Journal of Psychiatry : the Journal of Mental Science|August 1, 1997
Executive (frontal) dysfunction and negative symptoms in schizophrenia: apparent gender differences in 'static' v. 'progressive' profilesP J Scully, G Coakley, A Kinsella, et al.Psychological Medicine|December 24, 1997
Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophreniaP J Scully, G Coakley, A Kinsella, et al.Archives of General Psychiatry|October 1, 1987
Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormalityJ L Waddington, H A Youssef, C Dolphin, et al.Physician Assistant Clinics|September 5, 2022
Obstetric Emergency Update: Severe Acute Respiratory Syndrome COVID-19 and HypertensionLori J Stack, Allisyn BradyThe Biochemical Journal|June 1, 1990
4-O-(1-carboxyethyl)-L-rhamnose, a second unique acidic sugar found in an extracellular polysaccharide from Butyrivibrio fibrisolvens strain 49R J Stack, D WeislederPageof 67